Foghorn Therapeutics Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Foghorn Therapeutics Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Foghorn Therapeutics Inc. Operating Lease, Payments for the quarter ending March 31, 2021 was $2.37M, a 420% increase year-over-year.
  • Foghorn Therapeutics Inc. annual Operating Lease, Payments for 2023 was $10.1M, a 1.61% increase from 2022.
  • Foghorn Therapeutics Inc. annual Operating Lease, Payments for 2022 was $9.99M, a 2.56% increase from 2021.
  • Foghorn Therapeutics Inc. annual Operating Lease, Payments for 2021 was $9.74M, a 216% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.1M +$161K +1.61% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $9.99M +$249K +2.56% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $9.74M +$6.65M +216% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $3.09M +$1.36M +78.3% Jan 1, 2020 Dec 31, 2020 10-K/A 2022-08-09
2019 $1.73M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.